Efficacy News and Research

RSS
Study finds methylene blue is a low-micromolar inhibitor of the the SARS-CoV-2 spike protein and ACE2 interaction

Study finds methylene blue is a low-micromolar inhibitor of the the SARS-CoV-2 spike protein and ACE2 interaction

Effectiveness of a 'test-and-treat' approach for identification and treatment of vitamin D insufficiency for prevention of COVID-19

Effectiveness of a 'test-and-treat' approach for identification and treatment of vitamin D insufficiency for prevention of COVID-19

Scientists describe use of PCR in detecting SARS-CoV-2 in paraffine-embedded tissues

Scientists describe use of PCR in detecting SARS-CoV-2 in paraffine-embedded tissues

Topologically designed antibody candidates for SARS-CoV-2 and cancer therapies

Topologically designed antibody candidates for SARS-CoV-2 and cancer therapies

Evusheld™ found to poorly neutralize Omicron in kidney transplant patients

Evusheld™ found to poorly neutralize Omicron in kidney transplant patients

Researchers characterize vaccines for infectious bronchitis virus

Researchers characterize vaccines for infectious bronchitis virus

CASCADE biosensor found to be effective in naked-eye SARS-CoV-2 RNA detection

CASCADE biosensor found to be effective in naked-eye SARS-CoV-2 RNA detection

Reduced kidney function caused by antithrombotic therapy can influence bleeding events

Reduced kidney function caused by antithrombotic therapy can influence bleeding events

Study shows third dose of Pfizer-BioNTech vaccine against COVID-19 is both safe and effective

Study shows third dose of Pfizer-BioNTech vaccine against COVID-19 is both safe and effective

A novel mRNA vaccine encoding delta RBD induces high neutralizing antibody titers

A novel mRNA vaccine encoding delta RBD induces high neutralizing antibody titers

Shorter course of antibiotics associated with fewer antibiotic resistance genes

Shorter course of antibiotics associated with fewer antibiotic resistance genes

New implantable biotechnology produces and releases CAR-T cells for attacking tumors

New implantable biotechnology produces and releases CAR-T cells for attacking tumors

INRS professor developing a glycoconjugate vaccine for melioidosis

INRS professor developing a glycoconjugate vaccine for melioidosis

Study investigates anti-SARS-CoV-2 antibody levels following Pfizer vaccine primary and booster regimens

Study investigates anti-SARS-CoV-2 antibody levels following Pfizer vaccine primary and booster regimens

UB-612 vaccine booster found to elicit high neutralizing antibody levels against SARS-CoV-2 Omicron

UB-612 vaccine booster found to elicit high neutralizing antibody levels against SARS-CoV-2 Omicron

Study evaluates humoral and cellular immune memory induced by different COVID-19 vaccines

Study evaluates humoral and cellular immune memory induced by different COVID-19 vaccines

Anti-spike SARS-CoV-2 antibody titer trends over 15 months in healthcare workers in Boston

Anti-spike SARS-CoV-2 antibody titer trends over 15 months in healthcare workers in Boston

Study identified multiple siRNAs spanning the SARS-CoV-2 genome with potent antiviral activity

Study identified multiple siRNAs spanning the SARS-CoV-2 genome with potent antiviral activity

Recombinant SARS-CoV-2 Delta-Omicron variant identified in the United States

Recombinant SARS-CoV-2 Delta-Omicron variant identified in the United States

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.